Emmanuelle Kempf

Documents

Publications

	Hospital end-of-life care aggressiveness in adult solid tumour patients pre and post COVID-19: retrospective multicentre cohort study Tanya Cassam Chenai , Mohamed El Mejdani , Ariel Cohen , Sonia Priou , Gilles Chatellier BMJ Palliative and supportive care, In press, ⟨10.1136/spcare-2024-004888⟩ Journal articles hal-04524336v1
	Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis Simon Marty , Guillaume Lamé , Etienne Guével , Sonia Priou , Gilles Chatellier BMC Cancer, 2024, 24 (1), pp.143. ⟨10.1186/s12885-023-11795-1⟩ Journal articles hal-04425493v1
	Development of a Natural Language Processing Model for deriving breast cancer quality indicators : A cross-sectional, multicenter study Etienne Guével , Sonia Priou , Rémi Flicoteaux , Guillaume Lamé , Romain Bey Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2023, 71 (6), pp.102189. ⟨10.1016/j.respe.2023.102189⟩ Journal articles hal-04288208v1
	Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review Léonard Depotte , Maryline Caroux , Joseph Gligorov , Florence Canouï-Poitrine , Yazid Belkacemi Health and Quality of Life Outcomes, 2023, 21 (1), pp.11. ⟨10.1186/s12955-023-02093-2⟩ Journal articles hal-03972057v1
	Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study ( ELCAPA ‐19) Déborah Assouan , Elena Paillaud , Philippe Caillet , Amaury Broussier , Emmanuelle Kempf Cancer Medicine, 2023, 12 (22), pp.20940-20952. ⟨10.1002/cam4.6639⟩ Journal articles hal-04604607v1
	How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in Urologic Cancers Emmanuelle Kempf , Morgan Vaterkowski , Damien Leprovost , Nicolas Griffon , David Ouagne JCO Clinical Cancer Informatics, 2023, 7, ⟨10.1200/CCI.22.00179⟩ Journal articles hal-04107871v1
	Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study Etienne Guével , Sonia Priou , Guillaume Lamé , Johanna Wassermann , Romain Bey Cancer Medicine, 2023, 12 (22), pp.20918-20929. ⟨10.1002/cam4.6637⟩ Journal articles hal-04267498v1
	No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS‐COV‐2 outbreak: A retrospective multicenter cohort study on real‐world data Emmanuelle Kempf , Sonia Priou , Guillaume Lamé , Alexis Laurent , Etienne Guével International Journal of Cancer, 2023, 153 (12), pp.1988-1996. ⟨10.1002/ijc.34675⟩ Journal articles hal-04189069v1
	Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group Pascaline Boudou‐rouquette , Elodie Martin , Emmanuelle Kempf , Nicolas Penel , Maud Toulmonde International Journal of Cancer, 2022, 150 (5), pp.825-836. ⟨10.1002/ijc.33837⟩ Journal articles hal-03560233v1
	Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicenter real-life cohort study Sonia Priou , Guillaume Lamé , Gerard Zalcman , Marie Wislez , Romain Bey European Journal of Cancer, 2022, 173, pp.33-40. ⟨10.1016/j.ejca.2022.06.018⟩ Journal articles hal-03705935v1
	Impact of two waves of Sars‐Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of University hospitals Emmanuelle Kempf , Sonia Priou , Guillaume Lamé , Christel Daniel , Ali Bellamine International Journal of Cancer, 2022, 150 (10), pp.1609-1618. ⟨10.1002/ijc.33928⟩ Journal articles hal-03519085v1
	Nestin as a Diagnostic and Prognostic Marker for Combined Hepatocellular-Cholangiocarcinoma. Julien Calderaro , Luca Di Tommaso , Pascale Maillé , Aurélie Beaufrère , Cong Trung Nguyen Journal of Hepatology, 2022, pp.S0168-8278(22)02983-X. ⟨10.1016/j.jhep.2022.07.019⟩ Journal articles hal-03760904v1
	Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials Guilherme Lopes , Christophe Tournigand , Curtis Olswold , Romain Cohen , Emmanuelle Kempf Clinical Trials, 2021, 18 (1), pp.51-60. ⟨10.1177/1740774520959313⟩ Journal articles hal-03560262v1
	Effect of the COVID-19 pandemic on colorectal cancer care in France Sonia Priou , Guillaume Lamé , Gilles Chatellier , Christophe Tournigand , Emmanuelle Kempf The Lancet Gastroenterology & Hepatology, 2021, 6 (5), pp.342 - 343. ⟨10.1016/S2468-1253(21)00095-9⟩ Journal articles hal-03197455v1
	New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of national lockdown Emmanuelle Kempf , Guillaume Lamé , Richard Layese , Sonia Priou , Gilles Chatellier European Journal of Cancer, 2021, 150, pp.260-267. ⟨10.1016/j.ejca.2021.02.015⟩ Journal articles hal-03172913v1
	Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review Aline Barhli , Marie-Liesse Joulia , Christophe Tournigand , Emmanuelle Kempf Critical Reviews in Oncology/Hematology, 2021, 157, pp.103162 -. ⟨10.1016/j.critrevonc.2020.103162⟩ Journal articles hal-03560258v1
	National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma? Emmanuelle Kempf , Gérard Zalcman , Céleste Lebbe Cancer, 2021, 127 (13), pp.2181-2183. ⟨10.1002/cncr.33495⟩ Journal articles hal-03560245v1
	Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study Marc-Antoine Benderra , Ainhoa Aparicio , Judith Leblanc , Demian Wassermann , Emmanuelle Kempf Cancers, 2021, 13 (19), pp.4749. ⟨10.3390/cancers13194749⟩ Journal articles hal-03379679v1
	Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review Aline Barhli , Marie-Liesse Joulia , Christophe Tournigand , Emmanuelle Kempf Critical Reviews in Oncology/Hematology, 2021, 157, pp.103162 -. ⟨10.1016/j.critrevonc.2020.103162⟩ Journal articles hal-03492652v1
	Complete response in anaplastic lymphoma kinase–rearranged oncocytic thyroid cancer: A case report and review of literature Victoire De Salins , Gokoulakrichenane Loganadane , Charlotte Joly , Mukedaisi Abulizi , Maya Nourieh World Journal of Clinical Oncology, 2020, 11 (7), pp.495-503. ⟨10.5306/wjco.v11.i7.495⟩ Journal articles hal-03560266v1
	Traitement des autres tumeurs solides métastatiques MSI/dMMR Clémentine Bouchez , Emmanuelle Kempf , Christophe Tournigand Bulletin du Cancer, 2019, 106, pp.143 - 150. ⟨10.1016/j.bulcan.2019.01.008⟩ Journal articles hal-03486636v1
	Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review Emmanuelle Kempf , Jennifer de Beyer , Jonathan Cook , Jane Holmes , Seid Mohammed British Journal of Cancer, 2018, 119 (10), pp.1288-1296. ⟨10.1038/s41416-018-0305-5⟩ Journal articles hal-03560279v1
	Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures Anthony Turpin , Jean-Marie Michot , Emmanuelle Kempf , Renaud Mazeron , Peggy Dartigues Bulletin du Cancer, 2018, 105 (1), pp.81-98. ⟨10.1016/j.bulcan.2017.11.008⟩ Journal articles hal-03560287v1
	Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study Emmanuelle Kempf , Christophe Tournigand , Philippe Rochigneux , Régis Aubry , Lucas Morin European Journal of Cancer, 2017, 79, pp.31-40. ⟨10.1016/j.ejca.2017.03.029⟩ Journal articles hal-03560299v1
	‘Mind the gap’ between the development of therapeutic innovations and the clinical practice in oncology: A proposal of the European Organisation for Research and Treatment of Cancer (EORTC) to optimise cancer clinical research Emmanuelle Kempf , Jan Bogaerts , Denis Lacombe , Lifang Liu European Journal of Cancer, 2017, 86, pp.143-149. ⟨10.1016/j.ejca.2017.08.028⟩ Journal articles hal-03560295v1
	Systemic treatment of renal cell cancer: A comprehensive review Amparo Sánchez-Gastaldo , Emmanuelle Kempf , Aránzazu González del Alba , Ignacio Duran Cancer Treatment Reviews, 2017, 60, pp.77-89. ⟨10.1016/j.ctrv.2017.08.010⟩ Journal articles hal-03560297v1
	Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience Emmanuelle Kempf , G. Desamericq , B. Vieites , I. Diaz-Padilla , E. Calvo Clinical and Translational Oncology, 2017, 19 (2), pp.173-179. ⟨10.1007/s12094-016-1517-x⟩ Journal articles hal-03560317v1
	Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge Daniel Satgé , Emmanuelle Kempf , Jean-Bernard Dubois , Motoi Nishi , Jean Trédaniel Lung Cancer International, 2016, 2016, pp.1-7. ⟨10.1155/2016/6787648⟩ Journal articles hal-03560308v1
	Les patients ambulatoires atteints de cancer sont-ils prêts pour la télémédecine ? Emmanuelle Kempf , Audrey Prévost , Benoit Rousseau , Isabelle Macquin-Mavier , Christophe Louvet Bulletin du Cancer, 2016, 103 (10), pp.841-848. ⟨10.1016/j.bulcan.2016.06.004⟩ Journal articles hal-03560307v1
	A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials Emmanuelle Kempf , Nathalie Lemoine , Gabrielle Tergemina-Clain , Anthony Turpin , Sophie Postel-Vinay PLoS ONE, 2016, 11 (5), pp.e0154895. ⟨10.1371/journal.pone.0154895⟩ Journal articles hal-03560319v1
	Two cases of immune thrombocytopenia associated with pembrolizumab Audrey Le Roy , Emmanuelle Kempf , Felix Ackermann , Emilie Routier , Caroline Robert European Journal of Cancer, 2016, 54, pp.172-174. ⟨10.1016/j.ejca.2015.10.073⟩ Journal articles hal-03560330v1
	First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis Benoît Rousseau , Emmanuelle Kempf , Gaelle Desamericq , Emilie Boissier , Marie Chaubet-Houdu Critical Reviews in Oncology/Hematology, 2016, 107, pp.44-53. ⟨10.1016/j.critrevonc.2016.08.012⟩ Journal articles hal-03560302v1
	KRAS oncogene in lung cancer: focus on molecularly driven clinical trials Emmanuelle Kempf , Benoît Rousseau , Benjamin Besse , Luis Paz-Ares European Respiratory Review, 2016, 25 (139), pp.71-76. ⟨10.1183/16000617.0071-2015⟩ Journal articles hal-03560322v1
	Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion Cindy Neuzillet , Samy Babai , Emmanuelle Kempf , Géraldine Pujol , Benoît Rousseau Medicine, 2016, 95 (26), pp.e4006. ⟨10.1097/MD.0000000000004006⟩ Journal articles hal-03560311v1
	Computer-based risk prediction models: Ethical issues of Adjuvant! Online use in early-stage breast cancer Emmanuelle Kempf , E. Azria , A. Kempf Gynécologie Obstétrique & Fertilité, 2016, 44 (2), pp.79-81. ⟨10.1016/j.gyobfe.2015.11.012⟩ Journal articles hal-03560326v1
	What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA-08 Cohort Study Emmanuelle Kempf , Philippe Caillet , Benoit Rousseau , Aurélie Le Thuaut , Sylvie Bastuji-Garin Journal of the American Geriatrics Society, 2016, 64 (6), pp.1360-1362. ⟨10.1111/jgs.14154⟩ Journal articles hal-03560315v1
	First Reported Case of Unexpected Response to an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the I744M Uncommon EGFR Mutation Emmanuelle Kempf , Ludovic Lacroix , Jean-Charles Soria Clinical Lung Cancer, 2015, 16 (6), pp.e259-e261. ⟨10.1016/j.cllc.2015.06.002⟩ Journal articles hal-03560333v1
	10-year long-term survival of a metastatic EGFR -mutated nonsmall cell lung cancer patient Emmanuelle Kempf , David Planchard , Thierry Le Chevalier , Jean-Charles Soria European Respiratory Journal, 2015, 46 (1), pp.280-282. ⟨10.1183/09031936.00017315⟩ Journal articles hal-03560338v1
	Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia Emmanuelle Kempf , Pierre Hirsch , Myriam Labopin , Frank Viguié , Françoise Isnard Leukemia Research, 2014, 38 (12), pp.1425-1429. ⟨10.1016/j.leukres.2014.09.013⟩ Journal articles hal-03560339v1
	Quelle utilité des directives anticipées pour les médecins ? Véronique Fournier , Denis Berthiau , Emmanuelle Kempf , Julie D’haussy La Presse Médicale, 2013, 42 (6), pp.e159-e169. ⟨10.1016/j.lpm.2012.09.027⟩ Journal articles hal-03560343v1
	Place des traitements ciblés dans la prise en charge des cancers broncho-pulmonaires L. Staudacher , L. Teixeira , Emmanuelle Kempf , G. Rousseau-Bussac , S. Jouveshomme Pathologie Biologie, 2012, 60 (4), pp.246-253. ⟨10.1016/j.patbio.2012.05.011⟩ Journal articles hal-03560346v1

	Impact de la COVID-19 sur la prise en charge des patients atteints de cancer en fin de vie à l'AP-HP A. Cohen , M. El Mejdani , T. Cassam Chenai , Guillaume Lamé , S. Priou Congrès EMOIS 2024, Apr 2024, Lille, France. pp.202208, ⟨10.1016/j.jeph.2024.202208⟩ Conference papers hal-04504381v1
	Modalités d'identification des patients éligibles à l'inclusion dans des essais cliniques en oncologie : une étude qualitative dans le cadre du programme PENELOPE A. La Rosa , Guillaume Lamé , M. Vaterkowski , M. Cuggia , B. Campillo-Gimenez Congrès EMOIS 2024, Apr 2024, Lille, France. pp.202209, ⟨10.1016/j.jeph.2024.202209⟩ Conference papers hal-04504388v1
	Utilisation du traitement automatique du langage pour le calcul et le suivi d'indicateurs de qualité de la prise en charge du cancer du sein E. Guével , S. Priou , Guillaume Lamé , R. Flicoteaux , Christophe Tournigand Congrès national Emois 2023, Mar 2023, Nancy, France. pp.101468, ⟨10.1016/j.respe.2023.101468⟩ Conference papers hal-04013120v1
	Valeur ajoutée des algorithmes de traitement automatique du langage: exemple de la prise en charge du cancer du pancréas à l'Assistance publique-Hôpitaux de Paris Sonia Priou , Guillaume Lamé , R. Flicoteaux , E. Guével , G. Chatellier Congrès national Emois 2023, Mar 2023, Nancy, France. pp.101464, ⟨10.1016/j.respe.2023.101464⟩ Conference papers hal-04013109v1
	Why Are Data Missing in Clinical Data Warehouses? A Simulation Study of How Data Are Processed (and Can Be Lost) Sonia Priou , Guillaume Lamé , Marija Jankovic , Gilles Chatellier , Romain Bey Medical Informatics Europe 2023, May 2023, Gothenburg, Sweden. pp.202-206, ⟨10.3233/shti230103⟩ Conference papers hal-04102386v1
	“In conferences, everyone goes ‘health data is the future’ ”: an interview study on challenges in re-using EHR data for research in Clinical Data Warehouses Sonia Priou , Guillaume Lamé , Marija Jankovic , Emmanuelle Kempf AMIA 2023 Annual Symposium, Nov 2023, New Orleans (LA), United States Conference papers hal-04285545v1
	1690O Impact of the SARS-CoV-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: A systematic review and meta-analysis S. Marty , Guillaume Lamé , E. Guével , Sonia Priou , G. Chatellier ESMO 2023, Oct 2023, Madrid, Spain. pp.S925, ⟨10.1016/j.annonc.2023.09.2644⟩ Conference papers hal-04253195v1
	Conséquences de la crise Covid-19 en oncologie médicale : promesses, réalisations et défis d'un entrepôt de données de santé Sonia Priou , Guillaume Lamé , Marija Jankovic , Romain Bey , Christel Daniel GISEH2022 - 11e Conférence Francophone en Gestion et Ingénierie des Systèmes Hospitaliers, Jul 2022, Saint Etienne, France Conference papers hal-03784013v1
	Classification multilabel de concepts médicaux pour l’identification du profil clinique du patient Christel Gérardin , Pascal Vaillant , Perceval Wajsbürt , Clément Gilavert , Ali Bellamine Traitement Automatique des Langues Naturelles, 2021, Lille, France. pp.21-30 Conference papers hal-03265917v1

	Identification et caractérisation des patients pris en charge à l'AP-HP pour deux cancers S. Priou , H. Demeure , Guillaume Lamé , G. Chatellier , R. Flicoteaux Congrès EMOIS 2024, Apr 2024, Lille, France. Journal of Epidemiology and Population Health, 72 (Suppl 1), pp.202308, 2024, ⟨10.1016/j.jeph.2024.202308⟩ Conference poster hal-04504369v1
	« Tous les congrès où l'on va, on dit que ‘les données de santé, c'est l'avenir’ » : étude par entretiens des défis de la réutilisation des données de santé Sonia Priou , Guillaume Lamé , M. Jankovic , Emmanuelle Kempf Congrès EMOIS, Apr 2024, Lille, France. Journal of Epidemiology and Population Health, 72 (Supp 1), pp.202307, 2024, ⟨10.1016/j.jeph.2024.202307⟩ Conference poster hal-04504362v1
	463P Impact of two waves of Sars-Cov-2 outbreak on the clinical presentation and outcomes of newly referred breast cancer cases at AP-HP: A retrospective multicenter cohort study Sonia Priou , E. Guével , Guillaume Lamé , J. Wassermann , R. Bey ESMO2023, Oct 2023, Madrid, Spain. Annals of Oncology, 34 (S2), pp.S376, 2023, ⟨10.1016/j.annonc.2023.09.639⟩ Conference poster hal-04253192v1
	2080P Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data O. Rohr , Sonia Priou , Guillaume Lamé , G. Chatelier , S. Babai ESMO 2023, Oct 2023, Madrid, Spain. Annals of Oncology, 34 (S2), pp.S1094-S1095, 2023, ⟨10.1016/j.annonc.2023.09.862⟩ Conference poster hal-04253191v1

	Le cancer en prison (CaPri) Philippe Combessie , Yvain Auger , Clara Brones , Gilles Chatellier , Aurélien Djakouane 18.32, IERDJ - Institut des Études et de la Recherche sur le Droit et la Justice. 2023 Reports hal-04353936v1

	Structuration, standardisation et enrichissement par traitement automatique du langage des données relatives au cancer au sein de l’entrepôt de données de santé de l’Assistance Publique – Hôpitaux de Paris Emmanuelle Kempf Santé publique et épidémiologie. Sorbonne Université, 2023. Français. ⟨NNT : 2023SORUS694⟩ Theses tel-04552534v2

Emmanuelle Kempf

Publications

Hospital end-of-life care aggressiveness in adult solid tumour patients pre and post COVID-19: retrospective multicentre cohort study

Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis

Development of a Natural Language Processing Model for deriving breast cancer quality indicators : A cross-sectional, multicenter study

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review

Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study ( ELCAPA ‐19)

How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in Urologic Cancers

Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study

No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS‐COV‐2 outbreak: A retrospective multicenter cohort study on real‐world data

Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group

Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicenter real-life cohort study

Impact of two waves of Sars‐Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of University hospitals

Nestin as a Diagnostic and Prognostic Marker for Combined Hepatocellular-Cholangiocarcinoma.

Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials

Effect of the COVID-19 pandemic on colorectal cancer care in France

New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of national lockdown

Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review

National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?

Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study

Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review

Complete response in anaplastic lymphoma kinase–rearranged oncocytic thyroid cancer: A case report and review of literature

Traitement des autres tumeurs solides métastatiques MSI/dMMR

Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review

Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures

Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study

‘Mind the gap’ between the development of therapeutic innovations and the clinical practice in oncology: A proposal of the European Organisation for Research and Treatment of Cancer (EORTC) to optimise cancer clinical research

Systemic treatment of renal cell cancer: A comprehensive review

Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Les patients ambulatoires atteints de cancer sont-ils prêts pour la télémédecine ?

A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials

Two cases of immune thrombocytopenia associated with pembrolizumab

First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis

KRAS oncogene in lung cancer: focus on molecularly driven clinical trials

Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion

Computer-based risk prediction models: Ethical issues of Adjuvant! Online use in early-stage breast cancer

What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA-08 Cohort Study

First Reported Case of Unexpected Response to an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the I744M Uncommon EGFR Mutation

10-year long-term survival of a metastatic EGFR -mutated nonsmall cell lung cancer patient

Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia

Quelle utilité des directives anticipées pour les médecins ?

Place des traitements ciblés dans la prise en charge des cancers broncho-pulmonaires

Impact de la COVID-19 sur la prise en charge des patients atteints de cancer en fin de vie à l'AP-HP

Modalités d'identification des patients éligibles à l'inclusion dans des essais cliniques en oncologie : une étude qualitative dans le cadre du programme PENELOPE

Utilisation du traitement automatique du langage pour le calcul et le suivi d'indicateurs de qualité de la prise en charge du cancer du sein

Valeur ajoutée des algorithmes de traitement automatique du langage: exemple de la prise en charge du cancer du pancréas à l'Assistance publique-Hôpitaux de Paris

Why Are Data Missing in Clinical Data Warehouses? A Simulation Study of How Data Are Processed (and Can Be Lost)

“In conferences, everyone goes ‘health data is the future’ ”: an interview study on challenges in re-using EHR data for research in Clinical Data Warehouses

1690O Impact of the SARS-CoV-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: A systematic review and meta-analysis

Conséquences de la crise Covid-19 en oncologie médicale : promesses, réalisations et défis d'un entrepôt de données de santé

Classification multilabel de concepts médicaux pour l’identification du profil clinique du patient

Identification et caractérisation des patients pris en charge à l'AP-HP pour deux cancers

« Tous les congrès où l'on va, on dit que ‘les données de santé, c'est l'avenir’ » : étude par entretiens des défis de la réutilisation des données de santé

463P Impact of two waves of Sars-Cov-2 outbreak on the clinical presentation and outcomes of newly referred breast cancer cases at AP-HP: A retrospective multicenter cohort study

2080P Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data

Le cancer en prison (CaPri)

Structuration, standardisation et enrichissement par traitement automatique du langage des données relatives au cancer au sein de l’entrepôt de données de santé de l’Assistance Publique – Hôpitaux de Paris

Modalités d'identification des patients éligibles à l'inclusion dans des essais cliniques en oncologie : une étude qualitative dans le cadre du programme PENELOPE

« Tous les congrès où l'on va, on dit que ‘les données de santé, c'est l'avenir’ » : étude par entretiens des défis de la réutilisation des données de santé